DigiCert and Panasonic Industry Europe Join Forces to Simplify and Accelerate Adoption of Matter Smart Home Device Certification
Lehi, Utah, May 15, 2025 (GLOBE NEWSWIRE) — DigiCert, a leading global provider of digital trust, today announced it has partnered with Panasonic Industry Europe to integrate DigiCert® Device Trust Manager with Panasonic's PAN-MaX intelligent manufacturing service for seamless Matter certification of interoperable smart home devices. The integration provides manufacturers with a faster, more efficient process for delivering secure, standards-compliant devices to market.
The partnership comes at a critical time as smart home device manufacturers face rising pressure to meet security, compliance, and interoperability demands amid rapid market growth. With the global smart home market projected to grow from $147.52 billion in 2025 to $633.20 billion by 2032 (CAGR of 23.1%, per Fortune Business Insights), the integration of DigiCert Device Trust Manager with Panasonic's PAN-MaX service streamlines Matter certification and accelerates delivery of secure, standards-compliant devices.
'DigiCert is a key contributor to Matter and one of the few trusted authorities that can issue Matter device attestation certificates,' said Kevin Hilscher, Senior Director, Product Management at DigiCert. 'Through our partnership with Panasonic Industry Europe, customers can now request certificates instantly through a fully automated system, eliminating extra steps and streamlining security. The process helps manufacturers focus on innovation, ensuring that security and Matter certification accelerate business rather than slow it down.'
'The smart home revolution requires a foundation of trust to thrive,' said Chetan Joshi, Lead Product Manager at Panasonic Industry Europe. 'Panasonic Industry Europe and DigiCert are setting a new standard for trust, where smart home devices aren't just connected, but secure and certified from the moment they're built. By combining Panasonic's innovative PAN-MaX certification service with DigiCert's industry-leading attestation services, we're making sure manufacturers have an effortless path to Matter certification without trading speed for security.'
For years, manufacturers have struggled with integrating security and certification into production. Too often, they're treated as an afterthought, leading to costly delays and compliance challenges. By integrating DigiCert Device Trust Manager with PAN-MaX, manufacturers receive: Automatic device attestation certificate (DAC) issuance: Certificates are requested and applied in real-time, without manual intervention and DAC provide encryption, identity, and authentication to devices. Built-in security and compliance: Wireless modules are Matter-ready, with authentication built in from day one. Faster time-to-market: No more waiting for manual certificate approvals. Security happens on the production line.
About Matter
Matter is the interoperability standard launched by the Connectivity Standards Alliance (CSA) and developed by the biggest names in smart home technology, including CSA members DigiCert and Panasonic. Matter aims to create a universal language that allows smart devices to communicate across ecosystems like Apple Home, Google Home, and Amazon Alexa.
For manufacturers, Matter compliance isn't just a feature —it's a requirement. Every Matter device must have a Device Attestation Certificate (DAC), a digital proof of compliance issued by a CSA-approved Product Attestation Authority (PAA). DigiCert is a PAA with many Matter certification customers. Without a DAC, a device simply won't function within a Matter ecosystem, creating delays, challenges and missed opportunities in an ultra-competitive market.
Resources:
Read the blog
Read more about PAN-MaX
About DigiCert
DigiCert is a leading global provider of digital trust, enabling individuals and businesses to engage online with the confidence that their footprint in the digital world is secure. DigiCert® ONE, the platform for digital trust, provides organizations with centralized visibility and control over a broad range of public and private trust needs, securing websites, enterprise access and communication, software, identity, content and devices. DigiCert pairs its award-winning software with its industry leadership in standards, support and operations, and is the digital trust provider of choice for leading companies around the world. For more information, visit www.digicert.com or follow us on LinkedIn.
About Panasonic Industry Europe GmbH
Panasonic Industry Europe GmbH is part of the global Panasonic Industry organization, one of the five major operating companies within Panasonic Holdings Corporation. Panasonic Industry Europe provides products and services for industrial customers all over Europe.
The company is committed to enabling customers to achieve their goals in a broad range of industrial sectors such as mobility, infrastructure, automation, medical, appliances, smart living, and security. With the know-how of devices and solution technologies, cultivated through a global mindset and over a century of tradition, Panasonic Industry collaborates closely with customers to create a sustainable future.
The broad and diverse product portfolio encompasses key electronic component sectors including electromechanical and passive components, batteries and other energy products, sensors and wireless connectivity modules, thermal management materials and custom solutions, as well as automation devices and solutions.
For more information, visit https://industry.panasonic.eu.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
7 hours ago
- Business Wire
Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in STELLAR-303 Phase 3 Pivotal Trial in Patients with Metastatic Colorectal Cancer
BUSINESS WIRE)-- Exelixis, Inc. (Nasdaq: EXEL) today announced positive topline results from the STELLAR-303 phase 3 pivotal trial in which zanzalintinib in combination with atezolizumab (Tecentriq ®) demonstrated a statistically significant improvement in overall survival (OS) versus regorafenib in the intent-to-treat (ITT) population of patients with previously treated non-microsatellite instability (MSI)-high metastatic colorectal cancer (CRC). These topline findings are from the final analysis conducted by the Independent Data Monitoring Committee of one of the dual primary endpoints of the STELLAR-303 phase 3 trial. The trial will proceed to the planned final analysis for the other dual primary endpoint of OS in patients without liver metastases (non-liver metastases, NLM). The safety profiles of zanzalintinib in combination with atezolizumab and of regorafenib were generally consistent with what has been previously observed, and no new safety signals were identified. The ITT population consisted of all randomized patients, regardless of the presence of liver metastases. The NLM subgroup consisted of patients who did not have active liver metastases at baseline as determined by investigator assessment. 'The STELLAR-303 results, which showed a survival benefit with the combination of zanzalintinib and atezolizumab versus regorafenib across all randomized patients with previously treated metastatic colorectal cancer, marks an important first milestone for our zanzalintinib pivotal development program,' said Amy Peterson, M.D., Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer, Exelixis. 'We look forward to discussing the findings with regulatory authorities and presenting the detailed results at an upcoming medical conference.' Secondary endpoints of STELLAR-303 include progression-free survival, objective response rate and duration of response in the ITT population and in the NLM subgroup of patients. Exelixis plans to submit detailed results of STELLAR-303 for presentation at an upcoming medical conference. About STELLAR-303 STELLAR-303 (NCT05425940) is a global, multicenter, randomized, phase 3, open-label study that randomized 901 patients 1:1 to either zanzalintinib (100 mg) in combination with atezolizumab or regorafenib. The study includes patients with previously treated non-MSI-high metastatic CRC. The dual primary endpoints of the study are OS in the ITT population and in the NLM subgroup of patients. Presence of liver metastases at baseline for all enrolled patients was determined by investigator assessment. Secondary endpoints include progression-free survival, objective response rate and duration of response in the ITT population and in the NLM subgroup of patients. More information about the trial is available at About Zanzalintinib Zanzalintinib is a third-generation oral tyrosine kinase inhibitor that inhibits the activity of receptor tyrosine kinases implicated in cancer growth and spread, including VEGF receptors, MET, AXL and MER. These receptor tyrosine kinases are involved in both normal cellular function and in pathologic processes such as oncogenesis, metastasis, tumor angiogenesis and resistance to multiple therapies, including immune checkpoint inhibitors. With zanzalintinib, Exelixis sought to build upon its extensive experience with the target profile of cabozantinib, the company's flagship medicine, while improving key characteristics, including pharmacokinetic half-life. Zanzalintinib is currently being developed for the treatment of advanced solid tumors, including colorectal cancer, kidney cancer, head and neck cancer and neuroendocrine tumors. Zanzalintinib is an investigational agent that is not approved for any use and is the subject of ongoing clinical trials. About CRC CRC is the third most common cancer and the second leading cause of cancer-related deaths in the U.S. 1 Approximately 154,000 new cases will be diagnosed in the U.S. with around 53,000 expected deaths from the disease in 2025. 1 CRC is most frequently diagnosed among people aged 65-74 and is more common in men and in people of non-Hispanic American Indian/Alaska Native descent. 2 Nearly a quarter of CRC cases are diagnosed at the metastatic stage, at which point the five-year survival rate is just 16.2%. 2 The liver is the most common site for CRC metastasis. Liver metastases significantly impact survival, with a median five-year survival rate of less than 14% when treated with palliative chemotherapy. 3 About Exelixis Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by drug discovery and development excellence, we are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules, antibody-drug conjugates and other biotherapeutics. This comprehensive approach harnesses decades of robust investment in our science and partnerships to advance our investigational programs and extend the impact of our flagship commercial product, CABOMETYX ® (cabozantinib). Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more patients hope for the future. For information about the company and its mission to help cancer patients recover stronger and live longer, visit follow @ExelixisInc on X (Twitter), like Exelixis, Inc. on Facebook and follow Exelixis on LinkedIn. Forward-Looking Statements This press release contains forward-looking statements, including, without limitation, statements related to: the therapeutic potential of the combination of zanzalintinib in combination with atezolizumab to improve overall survival in patients with metastatic CRC; Exelixis' plans to discuss the trial data from STELLAR-303 with regulatory authorities and to present detailed findings at an upcoming medical conference; and Exelixis' scientific pursuit to create transformational treatments that give more patients hope for the future. Any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and are based upon Exelixis' current plans, assumptions, beliefs, expectations, estimates and projections. Forward-looking statements involve risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in the forward-looking statements as a result of these risks and uncertainties, which include, without limitation: the availability of data at the referenced times; complexities and the unpredictability of the regulatory review and approval processes in the U.S. and elsewhere; Exelixis' continuing compliance with applicable legal and regulatory requirements; unexpected concerns that may arise as a result of the occurrence of adverse safety events or additional data analyses of clinical trials evaluating zanzalintinib; Exelixis' dependence on third-party vendors for the development, manufacture and supply of zanzalintinib; Exelixis' ability to protect its intellectual property rights; market competition; changes in economic and business conditions; and other factors affecting Exelixis and its development programs detailed from time to time under the caption 'Risk Factors' in Exelixis' most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, and in Exelixis' future filings with the Securities and Exchange Commission. All forward-looking statements in this press release are based on information available to Exelixis as of the date of this press release, and Exelixis undertakes no obligation to update or revise any forward-looking statements contained herein, except as required by law. Exelixis, the Exelixis logo and CABOMETYX are registered U.S. trademarks of Exelixis. TECENTRIQ is a registered U.S. trademark of Genentech, a member of the Roche Group. ___________________________ 1 Key Statistics for Colorectal Cancer. ACS website. Available at: Accessed June 2025. 2 Cancer Stat Facts: Colorectal Cancer. SEER website. Available at: Accessed June 2025. 3 Ros J, Salva F, Dopazo C, et al. Liver transplantation in metastatic colorectal cancer: are we ready for it? Br J Cancer. May 2023;128(10):1797-1806.
Yahoo
2 days ago
- Yahoo
AppLovin: The advertising giant in the making
Introduction AppLovin is a premier mobile technology company that has transitioned from a mobile gaming developer to a full-fledged app marketing and monetization platform. It was established in 2012 and is based in Palo Alto, California. The company operates two main business units: Software Platform and Apps. The Software Platform, which is driven by the AI-based AXON engine, is aimed at mobile app developers and it provides them with cutting-edge solutions like user acquisition, monetization, and analytics. This platform is responsible for handling billions of ad requests on a daily basis, as it leverages machine learning algorithms to improve campaign performance and to increase revenue for both advertisers and publishers. Among the key products offered are the MAX mediation platform which is the instrument that allows publishers to operate several ad networks with a single integration, and thorough user acquisition tools that are specifically designed for developers to grow their user bases at the shortest time possible. Warning! GuruFocus has detected 3 Warning Sign with APP. Key Growth Drivers Machine Learning and AI-Powered Optimization The AXON platform that is powered by AppLovin's sophisticated machine learning infrastructure, which is its own product, is the genetic code of the tech advantage of the company. The proprietary AI engine that the company uses, being at the heart of the whole process, is in charge of the incredible computational task of processing a diverse range of data to make real-time decisions on the best ad placements, user acquisition campaigns, and monetization strategies available. By examining the engagement metrics and conversion data, the system constantly improves the targeting accuracy and campaign efficiency besides getting insight from user behavior patterns. This exceptional efficiency, which allows advertisers to make more informed bids on ad inventory while publishers to generate more revenue, is based on the system's predictive capabilities. The platform's establishment to process and learn from billions of pieces of data each day creates a significant barrier for other competitors, as it is developed better with more available data. AXON is the neural network that drives the whole platform with deep learning technology, which is used to explore the user data in a way that traditional analysis tools would not be able to. That is to say, this platform is the most modern digital solution that performs the task of reinforcement learning, where the smart algorithms are given real-time feedback with optimal ad placement and bidding decisions generated automatically. This automated optimization function, which in reality results in the use of less human resources, is achieved compared to the delivering of impressive results using a set of predefined rules. Real-Time Bidding and Programmatic Infrastructure AppLovin has the technology stack including high-performance real-time bidding (RTB) infrastructure capable of processing hundreds of thousands of bid requests per second with sub-100 millisecond response times. This is a low-latency system for mobile advertising where split-second decisions are the determinants of campaign success. The distributed architecture of the platform ensures global scalability and uniform performance, despite different geographic regions. Moreover, the programmatic advertising technology platform includes header bidding alongside the integration allowing publishers to increase their revenue through enabling multi-demand sources to compete for the same inventory simultaneously. The system's complex auction mechanics are not only concerned with bid prices but also take into account user experience, ad quality, and long-term value optimization. However, Applovin's server-side integration mechanisms spare the technical brunt of application developers while presenting centralized data collection and analysis techniques. This approach is compared to client-side implementations, which need multiple SDK integrations, resulting in longer app latency and poor user experience. Data Analytics and Attribution Technology The advanced data analytics structure of the company processes the huge amounts of data it collects to find insights that are valuable for both the advertisers and publishers. More advanced attribution models, in turn, allow for better measurement of the user paths across multiple touchpoints, which translates into higher confidence in the budget allocation decisions. The two ways to attribute the platform's capability are probabilistic and deterministic, which are useful for a much dense privacy environment. AppLovin's analytics tool provides sophisticated analysis of cohorts, predicting lifetime value, and churn modeling to the app developers in an effort to enhance the user acquisition process. The platform's ability to connect the costs of acquiring new users with the value they bring over time means it can help optimize return on ad investment (ROAS) more than measuring just installs can. The company's commitment to using privacy-friendly methods in data collection and analysis ensures that it is well-prepared for the ever-changing legal landscape. Data confidentiality and federated learning methods, together with innovative approaches in data collection, will facilitate users' right to privacy, and continue the optimization process by respecting regulatory mandates. Competition from Technology Giants AppLovin is up against robust competition from technology companies that are using their resources and networks. Google, through its AdMob platform and Google Ads ecosystem, is probably the strongest rival. Google's interconnectedness with Android, YouTube, and its advertising network turned it into a powerhouse that promises premium exposure and fine contracts. Facebook (Meta), through its Audience Network along with the vast amount of data from social media, which makes it possible for precise user targeting and cross-platform campaign management, is another relevant competitor. Apple's recent privacy policies, namely, App Tracking Transparency (ATT), are a mixed-source benefit in the competition scene. The fact is that these issues eliminate some of the attribution and targeting capabilities for a while but at the same time, that would bring balance to the situation by lessening the data advantages that some of the competitors had before. The way to deal with this threat is a concentration on those areas where the giants might not be as swift or/and comprehensive. The deep dive on the mobile gaming and app monetization areas by the company grants the right for more in-depth verticals and exactly tailor-made solutions rather than platform companies do. The optimization brought along with the AXON platform's automatic algorithms for the mobile app environment often results in better performance than generic ad solvers in the scope of new user quality and monetization efficiency. Competition from Specialist Ad Tech Companies The mobile advertising game is competitive with the participation of many niche players, each of whom has identified a particular slice of the market. Unity Technologies is one of them, in particular, because it uses its Unity Ads platform to operate in the same arena as mobile gaming ads and even leverage its game development engine to provide integrated advertising. IronSource (now part of Unity) used to be a significant adversary with its all-in-one platform that handled app monetization and user acquisition comprehensively. Chartboost has a very specific operation model that enables it to focus only on mobile game advertising, which includes direct publisher relationships and extensive knowledge of the gaming industry. Vungle (now part of Liftoff) is a firm that, through its video ad solutions, has added strong creative optimization capabilities. These companies are mostly known for their vibrant industry knowledge and long-standing partnerships defined within the industry sectors. However, these specialized players are giving a tough time with their niche focus, AppLovin is competing against them by bringing extra scale and high-level technology. The yield of billions and billions of ad requests daily makes the company to have the capacity of more effective machine learning optimizationin and standard machine learning schemes. AppLovin's user acquisition, monetization, and analytics in one solution platform and the simplicity of not having to carry out multiple integrations delivers accessibility and effectiveness over single point solutions that require integrations. Strengthened by the right acquisitions, the company is in a stronger position as it has consolidated its market share, and the potential competition was eliminated. The MoPub acquisition from Twitter gave AppLovin a digital publisher relationship and mediation capabilities while other small acquisitions enriched the tech stack and human resources, thus enhancing the platform. Key Risks Risks of Platform Dependency and Ecosystem Control AppLovin is at a high risk concerning the technological factors stemming from its reliance on mobile platforms governed by Apple and Google. Any iOS and Android platform policy changes can, in a matter of seconds, thus alter the way AppLovin operates. The real-time impact of the implementation of Apple's App Tracking Transparency (ATT) framework proved this vulnerability when mobile advertisers immediately lost the ability to accurately attribute and target their ads. The prospective platform issues may involve more rigorous SDK approval processes, more privacy restrictions, or modified app store policies that will limit the advertising functionality altogether. For instance, the introduction of Private Relay in iOS 17 and the addition of enhanced tracking protection greatly narrow data collection capabilities. Although the Privacy Sandbox initiative from Android is still in progress, it poses a serious risk of redefining the way mobile advertising attribution and targeting are done. The technical risk branch out to the potential scenarios of platform fragmentation in which different versions of iOS or Android impose different privacy and advertising restrictions. AppLovin's single platform strategy is rendered more complex as it needs to reconcile with the different technical requirements caused by the braid of platform versions and geographic regions with various regulatory frameworks. Algorithmic and Machine Learning Model Vulnerabilities AXON's machine learning algorithms are the backbone of AppLovin's business edge as they grant a strongly concentrated technical risk around model performance and accuracy. The susceptibility of machine learning models to concept drift, where changing user behavior patterns or market conditions reduce the effectiveness of the model over time, is one of the most common reasons for this fall. The constant mutation of the mobile advertising ecosystem can make the previously useful alphas to be of no use whatsoever. Model bias is another highlight technical risk, this is when the algorithms inadvertently discriminate against some user segments or app categories, which in turn could result in regulatory violations or suboptimal performance outcomes. Attacks that are deceitful to the machine learning systems could influence either the bidding algorithms or the attribution models, which will in turn lead to financial losses and site degradation. The scenario of being data poisoned where the hackers introduce the useless and malicious data into the training datasets has the detrimental effect of degrading the performance of the models or creating vulnerabilities which can be exploited. The scale at which AppLovin is processing data, daily handling over billions of events, is making it more difficult to ensure comprehensive data validation while maintaining the real-time processing needs. The most serious of the risks that are created through overfitting is the one that comes from the models completely specializing in what has been done historically, thereby rendering the generalization capacities for new market conditions or user behaviors very weak. The high focus on the gaming vertical that has led to a competitive advantage could be detrimental if the gaming industry undergoes a drastic change. Valuation The forward P/E ratios for AppLovin portray impressive earnings acceleration with the non-GAAP P/E declining from 45.93x (FY1) to 27.69x (FY3), which suggests an impressive earnings increase, outstripping all but one peer company. It is the market's strong response that makes the compression evident, showing that it appreciates AppLovin's ability to grow the business while also keeping profitability up. The company's PEG ratios of 0.94 (non-GAAP forward) and 0.31 (GAAP TTM) are at a high level with respect to the growth rates making the stock very attractive, at least, it is significantly more attractive than peers like Adobe (1.35) and Cadence (3.09). This fact shows that the value of AppLovin is off the charts due to its markdown price based on its growth potential, which is further elaborated by the large upside that is now available. In contrast to industry rivals, AppLovin's valuation metrics look realistic even if the absolute P/E ratios are higher. Adobe and Cadence declare lesser P/E compression over time, while AppLovin shows signs of higher earnings growth. The absence of profit for a company like MasterCard (negative P/Es) contrasts sharply with AppLovin's prevailing profits in the ad-tech sector. Guru Holdings Lowenstein's 17.19% stake which is equivalent to $762.85 million shows tremendous conviction, especially if we take into consideration the average buy price that he had of $75.06, which is representing a 423.6% gain. Lowenstein's convincing position, which is large in size and yields excellent returns, is an evidence of AppLovin's strategic execution and its growth path. The 12.86% increase in the holdings that Lowenstein took just lately proves that he still has confidence in the company despite the stock's larger rise, which in turn shows that the bottom line is the company's fundamentals rather than the ups and downs of the market. Resnick's 13.47% stake ($740.26M) with an average cost basis of $49.41 (695.4% gain) represents even earlier conviction in AppLovin's transformation story. The stability of his holdings (0% recent change) indicates dissatisfaction with current positioning while maintaining long-term conviction. Both managers' five-star ratings and substantial outperformance demonstrate their investment expertise. ConclusionAppLovin faces strong competition from technology companies like Google, Facebook, and Apple. Google's AdMob platform and Ads ecosystem, coupled with its interconnectedness with Android, YouTube, and its advertising network, offer premium exposure and fine contracts. Facebook's Audience Network and vast data from social media enable precise user targeting and cross-platform campaign management. Apple's recent privacy policies, App Tracking Transparency (ATT), provide mixed-source benefits in the competition scene, but may limit data advantages. To address this threat, AppLovin focuses on mobile gaming and app monetization areas, offering tailored solutions rather than generic ad solvers. The AXON platform's automatic algorithms for the mobile app environment often result in better performance than generic ad solvers in terms of user quality and monetization efficiency. This article first appeared on GuruFocus. Sign in to access your portfolio
Business Insider
2 days ago
- Business Insider
Aliko Dangote eyes Namibia for the next big investment move amid pan-African expansion
Aliko Dangote, billionaire and one of the most prominent African investors, is considering Namibia as a potential destination for his group's extensive investment portfolio. Billionaire Aliko Dangote considers Namibia for expanding his investment portfolio. His investment approach emphasizes Africa-wide economic self-reliance and development. Namibia is implementing strategies in green hydrogen and private sector collaborations. Fresh off the completion of what is now the world's largest oil refinery, Dangote hinted at his plans to expand into Namibia during a high-level meeting with President Netumbo Nandi-Ndaitwah in Windhoek this week. The visit marks another step in the Dangote Group 's ongoing expansion into energy and industrial markets across over a dozen African countries, including South Africa, Ethiopia, Zambia, and Tanzania. ' Africa is Africa. It's not about Nigeria alone. If we sit back, there is no entrepreneur; whether from Japan, the U.S., or elsewhere, who can come and build our continent for us. ' The billionaire said. Why Namibia? Dangote's interest in the southern African nation aligns with its emerging green hydrogen strategy and energy ambitions, as well as its renewed focus on pan-African private sector partnerships. Most notably, he announced the completion of a 650,000-barrel-per-day oil refinery, now the largest in the world, alongside significant production capacities for polypropylene, fertilizer, LPG, and other industrial products. He stated, " We now have oil and gas. We've just finished building the largest refinery ever built, not just in Africa, but globally." 'We produce one million tonnes of polypropylene, carbon black feedstock, LPG, sulphate chips, and a fertilizer capacity of over three million tonnes; the second largest in the world." He added. The billionaire investor highlighted his $620 million investment in South Africa as part of a broader strategy to promote economic self-reliance and intra-African trade, stating,"It's not about Nigeria; it's about Africa. We must show that it can be done, and done by us." In response to his comments, President Nandi-Ndaitwah emphasized the need for African-owned investments to drive value addition and job creation. She said: " We are too few to be poor, considering the resources we have; both human and natural." "We don't want to be seen as a rich continent with poor people. African entrepreneurs like you give hope to the young ones that it is possible." She added. In a potential investor-wooing effort, she invited Dangote to consider Namibia as "a home away from home" and affirmed the country's readiness to support African-led investment projects with long-term local impact. 'When we meet successful African entrepreneurs like you, it is not just business; it is inspiration,' she said. 'Namibia is ready for this kind of partnership.' Nandi-Ndaitwah said.
